Deric D. Bryant - 16 Jul 2025 Form 4 Insider Report for ChampionX Corp (CHX)

Reporting relationship: Chief Operating Officer and President, Chemical Technologies
Issuer ticker: CHX
Reported as of: 16 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jul 2025, 10:00:39 UTC
Prior SEC filing: 20 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Julia Wright, as attorney-in-fact to Deric D. Bryant

Key filing fact

Deric D. Bryant filed Form 4 for ChampionX Corp (CHX) on 16 Jul 2025.

Key facts

This page summarizes Deric D. Bryant's Form 4 filing for ChampionX Corp (CHX).
5 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 16 Jul 2025, 10:00.

Change

Previous filing in this sequence was filed on 20 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001782476 Primary reporting owner

Bryant Deric D.

Relationship: Chief Operating Officer and President, Chemical Technologies
Address: C/O CHAMPIONX CORP, 2445 TECHNOLOGY, FOREST BLVD., BLDG. 4, 12TH FLOOR, THE WOODLANDS
Signature: /s/ Julia Wright, as attorney-in-fact to Deric D. Bryant
Signature date: 16 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHX transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -386,340
Change %: -100%
Price
Shares after: 0
Date: 16 Jul 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares: -52,540
Change %: -100%
Price
Shares after: 0
Date: 16 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 52,540
Exercise price: $5.67
Footnotes: F1, F3

CHX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares: -152,408
Change %: -100%
Price
Shares after: 0
Date: 16 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 152,408
Exercise price: $5.60
Footnotes: F1, F3

CHX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares: -290,541
Change %: -100%
Price
Shares after: 0
Date: 16 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 290,541
Exercise price: $6.53
Footnotes: F1, F3

CHX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares: -228,287
Change %: -100%
Price
Shares after: 0
Date: 16 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 228,287
Exercise price: $7.54
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Deric D. Bryant is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 2, 2024, by and among the Issuer, Schlumberger Limited ("SLB"), Sodium Holdco, Inc. and Sodium Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer with the Issuer continuing as the surviving corporation and an indirect wholly owned subsidiary of SLB (the "Merger").

Footnote F2

Pursuant to the Merger Agreement, among other things, (i) each outstanding share of common stock of the Issuer ("Common Stock") prior to the effective time of the Merger (the "Effective Time") was cancelled and converted into the right to receive 0.735 shares of SLB common stock ("SLB Common Stock" and such ratio, the "Exchange Ratio") and if applicable, cash in lieu of fractional shares and (ii) each outstanding restricted stock unit of the Issuer (an "RSU") was assumed and converted into a restricted stock unit award to acquire shares of SLB Common Stock, on the same terms and conditions that applied to each RSU immediately prior to the Effective Time (an "SLB RSU Award") except that, as of the Effective Time, the number of shares of SLB Common Stock subject to an SLB RSU Award is equal to the product of (A) the number of shares of Common Stock underlying the RSU multiplied by (B) the Exchange Ratio, rounded down to the nearest whole share.

Footnote F3

In accordance with the terms of the Merger Agreement, each stock option of the Issuer (each, a "Company Option") that was outstanding immediately prior to the Effective Time was terminated and cancelled in exchange for an option to acquire shares of SLB Common Stock equal to the product of (A) the number of shares of Common Stock underlying such Company Option as of immediately prior to the Effective Time, multiplied by (B) the Exchange Ratio, rounded down to the nearest whole number, at a per-share exercise price equal to the quotient obtained by dividing (i) the per-share exercise price of the Company Option by (ii) the Exchange Ratio, rounded up to the nearest whole cent.

SEC remarks

Chief Operating Officer and President, Chemical Technologies